| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |


*
Division of Nephrology, Toronto General Hospital, University of Toronto,
Toronto, Ontario, Canada.
Department of Clinical Epidemiology and Biostatistics, McMaster
University, Hamilton, Ontario, Canada.
Father Sean O'Sullivan Research Center, St. Joseph's Hospital, Division of
Nephrology, McMaster University, Hamilton, Ontario, Canada.
Correspondence to Dr. Joanne M. Bargman, Toronto General Hospital, 200 Elizabeth Street EN10-216, Toronto, Ontario M5G 2C4, Canada. E-mail: joanne.bargman{at}uhn.on.ca
Abstract. Studies of the adequacy of peritoneal dialysis and recommendations have assumed that renal and peritoneal clearances are comparable and therefore additive. The CANUSA data were reanalyzed in an effort to address this assumption. Among the 680 patients in the original CANUSA study, 601 had all of the variables of interest for this report. Adequacy of dialysis was estimated from GFR (mean of renal urea and creatinine clearance) and from peritoneal creatinine clearance. The Cox proportional-hazards model was used to evaluate the time-dependent association of these independent variables with patient survival. For each 5 L/wk per 1.73 m2 increment in GFR, there was a 12% decrease in the relative risk (RR) of death (RR, 0.88; 95% confidence interval [CI], 0.83 to 0.94) but no association with peritoneal creatinine clearance (RR, 1.00; 95% CI, 0.90 to 1.10). Estimates of fluid removal (24-h urine volume, net peritoneal ultrafiltration, and total fluid removal) then were added to the Cox model. For a 250-ml increment in urine volume, there was a 36% decrease in the RR of death (RR, 0.64; 95% CI, 0.51 to 0.80). The association of patient survival with GFR disappeared (RR, 0.99; 95% CI, 0.94 to 1.04). However, neither net peritoneal ultrafiltration nor total fluid removal was associated with patient survival. Although these results may be explained partly, statistically, by less variability in peritoneal clearance than in GFR, the latter seems to be physiologically more important than the former. The assumption of equivalence of peritoneal and renal clearances is not supported by these data. Recommendations for adequate peritoneal dialysis need to be reevaluated in light of these observations.
This article has been cited by other articles:
![]() |
X. Lin, A. Lin, Z. Ni, Q. Yao, W. Zhang, Y. Yan, W. Fang, A. Gu, J. Axelsson, and J. Qian Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients Nephrol. Dial. Transplant., February 1, 2010; (2010): gfq001v2 - gfq001. [Abstract] [Full Text] [PDF] |
||||
|
|
E. Vonesh ON SMALL SOLUTE CLEARANCE AND PATIENT OUTCOMES: EVIDENTIAL PRACTICE OR OBSERVATIONAL TREPIDATION? Perit. Dial. Int., November 1, 2009; 29(6): 623 - 629. [Abstract] [Full Text] [PDF] |
||||
|
|
M. Rumpsfeld, S. P. McDonald, and D. W. Johnson PERITONEAL SMALL SOLUTE CLEARANCE IS NONLINEARLY RELATED TO PATIENT SURVIVAL IN THE AUSTRALIAN AND NEW ZEALAND PERITONEAL DIALYSIS PATIENT POPULATIONS Perit. Dial. Int., November 1, 2009; 29(6): 637 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Park, D. K. Kim, T. I. Chang, H. W. Kim, J. H. Chang, S. Y. Park, E. Kim, S.-W. Kang, D.-S. Han, and T.-H. Yoo Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3520 - 3525. [Abstract] [Full Text] [PDF] |
||||
|
|
A. Akbari, G. Knoll, D. Ferguson, B. McCormick, A. Davis, and M. Biyani ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PERITONEAL DIALYSIS: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS Perit. Dial. Int., September 1, 2009; 29(5): 554 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-T. Liao, Y.-M. Chen, C.-C. Shiao, F.-C. Hu, J.-W. Huang, T.-W. Kao, H.-F. Chuang, K.-Y. Hung, K.-D. Wu, and T.-J. Tsai Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2909 - 2914. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, J. Oh, S. Kim, W. Chung, C. Ahn, S. G. Kim, and K.-H. Oh Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2899 - 2908. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Davies Preserving residual renal function in peritoneal dialysis: volume or biocompatibility? Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2620 - 2622. [Full Text] [PDF] |
||||
![]() |
E. Vilar, D. Wellsted, S. M. Chandna, R. N. Greenwood, and K. Farrington Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2502 - 2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jiang, J. Qian, W. Sun, A. Lin, L. Cao, Q. Wang, Z. Ni, Y. Wan, B. Linholm, J. Axelsson, et al. Better preservation of residual renal function in peritoneal dialysis patients treated with a low-protein diet supplemented with keto acids: a prospective, randomized trial Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2551 - 2558. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Davison, G. S. Jhangri, K. Jindal, and N. Pannu Comparison of Volume Overload with Cycler-Assisted versus Continuous Ambulatory Peritoneal Dialysis Clin. J. Am. Soc. Nephrol., June 1, 2009; 4(6): 1044 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Noordzij, N. M. C. Voormolen, E. W. Boeschoten, F. W. Dekker, W. J. Bos, R. T. Krediet, J. C. Korevaar, and for the NECOSAD study group Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1580 - 1587. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ignace, D. Fouque, W. Arkouche, J.-P. Steghens, and F. Guebre-Egziabher Preserved residual renal function is associated with lower oxidative stress in peritoneal dialysis patients Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1685 - 1689. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Coester, W. Smit, D. G. Struijk, and R. T. Krediet Peritoneal function in clinical practice: the importance of follow-up and its measurement in patients. Recommendations for patient information and measurement of peritoneal function NDT Plus, April 1, 2009; 2(2): 104 - 110. [Abstract] [Full Text] [PDF] |
||||
|
|
J. Portoles, G. del Peso, M. J. Fernandez-Reyes, M. A. Bajo, P. Lopez-Sanchez, and the GCDP PREVIOUS COMORBIDITY AND LACK OF PATIENT FREE CHOICE OF TECHNIQUE PREDICT EARLY MORTALITY IN PERITONEAL DIALYSIS Perit. Dial. Int., March 1, 2009; 29(2): 150 - 157. [Abstract] [Full Text] [PDF] |
||||
|
|
P. Tam PERITONEAL DIALYSIS AND PRESERVATION OF RESIDUAL RENAL FUNCTION Perit. Dial. Int., February 1, 2009; 29(Supplement_2): S108 - S110. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Power, N Duncan, and C Goodlad Advances and innovations in dialysis in the 21st century Postgrad. Med. J., February 1, 2009; 85(1000): 102 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fang, J. Qian, A. Lin, F. Rowaie, Z. Ni, Q. Yao, J. M. Bargman, and D. G. Oreopoulos Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre Nephrol. Dial. Transplant., December 1, 2008; 23(12): 4021 - 4028. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Farhat, F. J. van Ittersum, P. M. ter Wee, and C. E. Douma Conventional versus biocompatible peritoneal dialysis fluids: more questions than answers? NDT Plus, October 1, 2008; 1(suppl_4): iv46 - iv50. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haag-Weber The impact of residual renal function on survival Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2123 - 2126. [Full Text] [PDF] |
||||
![]() |
B. Canaud Residual renal function: the delicate balance betweenbenefits and risks Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1801 - 1805. [Full Text] [PDF] |
||||
![]() |
R. Paniagua, D. Amato, S. Mujais, E. Vonesh, A. Ramos, R. Correa-Rotter, and W. H. Horl Predictive Value of Brain Natriuretic Peptides in Patients on Peritoneal Dialysis: Results from the ADEMEX Trial Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 407 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Khawar, K. Kalantar-Zadeh, W. K. Lo, D. Johnson, and R. Mehrotra Is the Declining Use of Long-Term Peritoneal Dialysis Justified by Outcome Data? Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1317 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Han, S. C. Lee, S. V. Ahn, J. E. Lee, D. K. Kim, T. H. Lee, S. J. Moon, B. S. Kim, S.-W. Kang, K. H. Choi, et al. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2653 - 2658. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. W. Tang, Y. W. Ho, A. W. C. Tang, Y. Y. Cheng, F. H. Chiu, W. K. Lo, K. N. Lai, and for the Hong Kong Peritoneal Dialysis Study Group Delaying initiation of dialysis till symptomatic uraemia--is it too late? Nephrol. Dial. Transplant., July 1, 2007; 22(7): 1926 - 1932. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. H. Kamel Mohamed, I. M. Wahba, S. Watnick, S. B. Earle, W. M. Bennett, J. W. Ayres, and M. Y. Munar Administration of Tobramycin in the Beginning of the Hemodialysis Session: A Novel Intradialytic Dosing Regimen Clin. J. Am. Soc. Nephrol., July 1, 2007; 2(4): 694 - 699. [Abstract] [Full Text] [PDF] |
||||
|
|
R. T. Krediet 30 YEARS OF PERITONEAL DIALYSIS DEVELOPMENT: THE PAST AND THE FUTURE Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S35 - S41. [Abstract] [Full Text] [PDF] |
||||
|
|
H. Kawanishi and M. Moriishi CLINICAL EFFECTS OF COMBINED THERAPY WITH PERITONEAL DIALYSIS AND HEMODIALYSIS Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S126 - S129. [Abstract] [Full Text] [PDF] |
||||
|
|
P. K. Li and Y. L. Cheng THERAPEUTIC OPTIONS FOR PRESERVATION OF RESIDUAL RENAL FUNCTION IN PATIENTS ON PERITONEAL DIALYSIS Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S158 - S163. [Abstract] [Full Text] [PDF] |
||||
|
|
A. Y.-M. Wang CARDIOVASCULAR RISK FACTORS IN PERITONEAL DIALYSIS PATIENTS REVISITED Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S223 - S227. [Abstract] [Full Text] [PDF] |
||||
|
|
A. Y.-M. Wang THE "HEART" OF PERITONEAL DIALYSIS Perit. Dial. Int., June 1, 2007; 27(Supplement_2): S228 - S232. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bargman New Technologies in Peritoneal Dialysis Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 576 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Bargman Peritoneal dialysis solutions and patient survival: does wishing make it so? Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2684 - 2686. [Full Text] [PDF] |
||||
![]() |
K. S. Brimble, M. Walker, P. J. Margetts, K. K. Kundhal, and C. G. Rabbat Meta-Analysis: Peritoneal Membrane Transport, Mortality, and Technique Failure in Peritoneal Dialysis J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2591 - 2598. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Saxena and C. West Peritoneal dialysis: a primary care perspective. J Am Board Fam Med, July 1, 2006; 19(4): 380 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dittrich, H. Puttinger, M. Schillinger, I. Lang, T. Stefenelli, W. H. Horl, and A. Vychytil Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1334 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Moranne, S. Willoteaux, D. Pagniez, P. Dequiedt, and E. Boulanger Effect of iodinated contrast agents on residual renal function in PD patients Nephrol. Dial. Transplant., April 1, 2006; 21(4): 1040 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Cheung, M. V. Rocco, G. Yan, J. K. Leypoldt, N. W. Levin, T. Greene, L. Agodoa, J. Bailey, G. J. Beck, W. Clark, et al. Serum beta-2 Microglobulin Levels Predict Mortality in Dialysis Patients: Results of the HEMO Study J. Am. Soc. Nephrol., February 1, 2006; 17(2): 546 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Jaar, J. Coresh, L. C. Plantinga, N. E. Fink, M. J. Klag, A. S. Levey, N. W. Levin, J. H. Sadler, A. Kliger, and N. R. Powe Comparing the Risk for Death with Peritoneal Dialysis and Hemodialysis in a National Cohort of Patients with Chronic Kidney Disease Ann Intern Med, August 2, 2005; 143(3): 174 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schulman Mortality and Treatment Modality of End-Stage Renal Disease Ann Intern Med, August 2, 2005; 143(3): 229 - 231. [Full Text] [PDF] |
||||
![]() |
J. M. Bargman and T. A. Golper The importance of residual renal function for patients on dialysis Nephrol. Dial. Transplant., April 1, 2005; 20(4): 671 - 673. [Full Text] [PDF] |
||||
![]() |
A. Y.-M. Wang, J. Woo, M. Wang, M. M.-M. Sea, J. E. Sanderson, S.-F. Lui, and P. K.-T. Li Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function Nephrol. Dial. Transplant., February 1, 2005; 20(2): 396 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Davies Are PD patients with or without residual renal function qualitatively different--or are they simply at different stages of the continuum of progressive uraemia? Nephrol. Dial. Transplant., February 1, 2005; 20(2): 270 - 272. [Full Text] [PDF] |
||||
![]() |
A. Y.-M. Wang, M. Wang, J. Woo, C. W.-K. Lam, S.-F. Lui, P. K.-T. Li, and J. E. Sanderson Inflammation, Residual Kidney Function, and Cardiac Hypertrophy Are Interrelated and Combine Adversely to Enhance Mortality and Cardiovascular Death Risk of Peritoneal Dialysis Patients J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2186 - 2194. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Termorshuizen, F. W. Dekker, J. G. van Manen, J. C. Korevaar, E. W. Boeschoten, and R. T. Krediet Relative Contribution of Residual Renal Function and Different Measures of Adequacy to Survival in Hemodialysis Patients: An analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2 J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1061 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Chertow A 43-Year-Old Woman With Chronic Renal Insufficiency JAMA, March 10, 2004; 291(10): 1252 - 1259. [Full Text] [PDF] |
||||
![]() |
F. Termorshuizen, J. C. Korevaar, F. W. Dekker, J. G. van Manen, E. W. Boeschoten, and R. T. Krediet Hemodialysis and Peritoneal Dialysis: Comparison of Adjusted Mortality Rates According to the Duration of Dialysis: Analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2 J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2851 - 2860. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. McDonald, J. F. Collins, and D. W. Johnson Obesity Is Associated with Worse Peritoneal Dialysis Outcomes in the Australia and New Zealand Patient Populations J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2894 - 2901. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Brown, S. J. Davies, P. Rutherford, F. Meeus, M. Borras, W. Riegel, J. C. Divino Filho, E. Vonesh, and M. Van Bree Survival of Functionally Anuric Patients on Automated Peritoneal Dialysis: The European APD Outcome Study J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2948 - 2957. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K.-T. Li, K.-M. Chow, T. Y.-H. Wong, C.-B. Leung, and C.-C. Szeto Effects of an Angiotensin-Converting Enzyme Inhibitor on Residual Renal Function in Patients Receiving Peritoneal Dialysis: A Randomized, Controlled Study Ann Intern Med, July 15, 2003; 139(2): 105 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. A. M. Konings, J. P. Kooman, M. Schonck, D. G. Struijk, U. Gladziwa, S. J. Hoorntje, A. W. van der Wall Bake, F. M. van der Sande, and K. M. L. Leunissen Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study Nephrol. Dial. Transplant., April 1, 2003; 18(4): 797 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Chung, O. Heimburger, P. Stenvinkel, A. R. Qureshi, and B. Lindholm Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients Nephrol. Dial. Transplant., March 1, 2003; 18(3): 590 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Margetts and D. N. Churchill Acquired Ultrafiltration Dysfunction in Peritoneal Dialysis Patients J. Am. Soc. Nephrol., November 1, 2002; 13(11): 2787 - 2794. [Full Text] [PDF] |
||||
![]() |
R. T. Krediet The rise and fall of the Kt/V concept in CAPD Nephrol. Dial. Transplant., June 1, 2002; 17(6): 970 - 972. [Full Text] [PDF] |
||||
![]() |
R. Paniagua, D. Amato, E. Vonesh, R. Correa-Rotter, A. Ramos, J. Moran, and S. Mujais Effects of Increased Peritoneal Clearances on Mortality Rates in Peritoneal Dialysis: ADEMEX, a Prospective, Randomized, Controlled Trial J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1307 - 1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Churchill The ADEMEX Study: Make Haste Slowly J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1415 - 1418. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673